Editas Medicine (EDIT) Reports Q4 Loss of $1.00/sh

Editas Medicine (NASDAQ: EDIT) reported Q4 EPS of ($1.00), versus ($0.74) reported last year. Revenue for the quarter came in at $11.4 million, versus $12.3 million reported last year.

For earnings history and earnings-related data on Editas Medicine (EDIT) click here.

You May Also Be Interested In

• NVIDIA stock gains as SemiAnalysis sees H2 data center revenue 20% above consensus
• Eversource completes $2.4B sale of Aquarion Water Company
• Nike (NKE) PT Lowered to $60 at Guggenheim